- Meeting abstract
- Published:
Impact of CVVH on monocyte activation in the critically ill
Critical Care volume 4, Article number: P37 (2000)
Full text
Introduction
Monocyte activation (HLA-DR+ CD14+) was suggested to be a useful marker of immune system function. As extracorporeal circuit might influence the immune response (e.g. bioincompatibility and/or elimination of pro/anti-inflammatory cytokines) we investigated the impact of CVVH initiation on monocyte activation in critically ill patients.
Methods
Fifteen septic (4 ICU survivors) and 7 nonseptic (1 ICU survivor) critically ill patients in whom CVVH (ultra-filtration 1–2 l h-1) was initiated because of acute renal failure as a part of MODS. Expression of HLA-DR+ CD14+ was assessed by flow-cytometry before CVVH initiation and at 4 h and 24 h afterwards. The Friedmann two-way ANOVA and Mann-Whitney U tests were used when appropriate. Data are presented as means ± SD; P<0.05 was considered significant.
Results
Baseline HLA-DR+CD14+ values in septic and non-septic patients were not different (57± 21% and 71± 21% respectively, P=0.23). Time course of HLA-DR+CD14+ during the first 24h of CVVH are shown in Fig. 1.
Conclusion
CVVH initiation has no impact on monocyte HLA-DR expression in both septic and nonseptic patients.
![figure 1](http://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fcc757/MediaObjects/13054_2000_Article_797_Fig1_HTML.jpg)
Figure 1
Acknowledgement
Supported by a Grant of IGA MZ (4972-3).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rokyta, R., Holub, M., Matejovic, M. et al. Impact of CVVH on monocyte activation in the critically ill. Crit Care 4 (Suppl 1), P37 (2000). https://doi.org/10.1186/cc757
Published:
DOI: https://doi.org/10.1186/cc757